Moderate to severe psoriasis treatment challenges through the era of biological drugs

• Type: Another Publication in an International Scientific Journal
• Date: 2017

Authors

Vide, J (Author) Other; magina, s (Author) FMUP

Journal

Title: Anais Brasileiros de Dermatologia

Vol. 92

Pages: 667-673

ISSN: 0365-0596

Publisher: Elsevier

Indexing

ISI Web of Knowledge - 20 Citations

Scopus - 25 Citations

Other information

Authenticus ID: P-00N-93S

DOI: 10.1590/abd1806-4841.20175603

Abstract (EN): Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety and efficacy. There are also clinical forms of the disease and patient profiles for which is pending further scientific evidence for more sustained therapeutic interventions. The continuous and more detailed knowledge of psoriasis pathophysiology has allowed identifying new therapeutic targets, which is expected to help overcome the challenges of individualized psoriasis treatment.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 7